TRASYLOL 500000KUI / 50ml infusion solution medication leaflet

B02AB01 aprotinin • Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors

Aprotinin is a protease inhibitor used to reduce blood loss during major surgical procedures, such as cardiac surgery with cardiopulmonary bypass. It works by inhibiting proteolytic enzymes such as trypsin, plasmin, and kallikrein, thereby preventing fibrin degradation and reducing the risk of excessive bleeding.

Aprotinin is administered intravenously, usually during surgery, according to a specific protocol. It is often used in patients at high risk of bleeding or requiring massive transfusions.

Side effects may include allergic reactions, renal failure, or thrombotic events. Its use requires careful monitoring, especially in patients with pre-existing conditions.

Aprotinin is a valuable medication in managing intraoperative blood loss, helping to reduce the need for transfusions and improve surgical outcomes.

General data about TRASYLOL 500000KUI / 50ml

Substance: aprotinin

Date of last drug list: 01-06-2025

Commercial code: W70952001

Concentration: 500000KUI / 50ml

Pharmaceutical form: infusion solution

Quantity: 1

Product type: generic

Price: 748.71 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FRESENIUS KABI AUSTRIA GMBH - AUSTRIA

Holder: PHARMA PROMOTION S.R.L. - ROMANIA

Number: 1037/2025/01

Shelf life: 3 years

Pharmaceutical forms available for aprotinin

Concentrations available for aprotinin

100000KUI/ml, 10000UKI, 500000KUI/50ml, 500000UIK